About Us

We work collaboratively with our clients to build strong, sustainable relationships. Our team is committed to delivering consistent high standards of service, and we understand the importance of accessibility. Working with us, you'll enjoy open communication, meaning well scoped, properly resourced and effectively managed matters.

Learn More

Latest Case

Advising on tech company IPOs July 6, 2018

Silicon Valley-based technology company Pivotal Systems launched an initial public offering (IPO) and listing on the Australian Securities Exchange (ASX) on 2 July 2018. The IPO raised $53.5 million, placing the value of the specialist … Continued

Latest News

Maddocks acts on major mining acquisition July 17, 2018

Tuesday 17 July 2018 Law firm Maddocks has advised Consolidated Mining & Civil Pty Ltd (CMC) on its purchase of 100 percent of Benagerie Gold Pty Ltd, which holds the Benagerie mining lease, from Havilah … Continued

Latest Article

NSW Crown land reforms have commenced – what do local councils need to know? July 18, 2018

The majority of the Crown Land Management Act 2016 (NSW) (the Act) commenced on 1 July 2018. The Act significantly reforms the use and management of Crown land in NSW. This article provides an overview of the key reforms, … Continued

Medibank cleared of all ACCC allegations

Over the past 18 months The Prescription has commented on the ACCC’s strategic focus on the private health insurance sector and, in particular, the issue of communicating detrimental changes to policy holders.

A key aspect of the ACCC’s approach to the private health insurance sector has been a proposition that – from the perspective of the consumer – there is no distinction between a change in benefits because of a rule change and a change in benefits because of a change in underlying contracting arrangements with providers.  That proposition was dealt a significant blow by the Federal Court yesterday, with the dismissal of the ACCC’s proceedings against Medibank alleging misleading and deceptive conduct and unconscionable conduct.  The Federal Court rejected the ACCC’s proposition, readily drawing a distinction between a change in benefits arising from a rule change and a change in benefits due to a change in underlying contractual arrangements.

Our commentary on the outcome of the Medibank proceedings is available here.

 

Author:   
Aaron Kloczko 2cm colour 300ppi 2013 jpg Aaron Kloczko
Partner
61 2 9291 6231
aaron.kloczko@maddocks.com.au

Over the past 18 months The Prescription has commented on the ACCC’s strategic focus on the private health insurance sector and, in particular, the issue of communicating detrimental changes to policy holders.

A key aspect of the ACCC’s approach to the private health insurance sector has been a proposition that – from the perspective of the consumer – there is no distinction between a change in benefits because of a rule change and a change in benefits because of a change in underlying contracting arrangements with providers.  That proposition was dealt a significant blow by the Federal Court yesterday, with the dismissal of the ACCC’s proceedings against Medibank alleging misleading and deceptive conduct and unconscionable conduct.  The Federal Court rejected the ACCC’s proposition, readily drawing a distinction between a change in benefits arising from a rule change and a change in benefits due to a change in underlying contractual arrangements.

Our commentary on the outcome of the Medibank proceedings is available here.

 

Author:   
Aaron Kloczko 2cm colour 300ppi 2013 jpg Aaron Kloczko
Partner
61 2 9291 6231
aaron.kloczko@maddocks.com.au